• 한국보건간호학회지
• /
• 제33권3호
• /
• pp.326-339
• /
• 2019

Purpose: This study attempts to identify the level of awareness, ethical awareness, and decision-making among nursing students, in response to pandemic infectious diseases. Methods: Subjects were 210 nursing college students attending colleges in 5 cities and provinces nationwide. Data were collected from November 2017 to April 2018 using a self-administrated questionnaire, and analyzed utilizing descriptive statistics. Results: Considering the awareness of pandemic infectious diseases, the nursing students expressed high concern about the possibility of future outbreaks of pandemic infectious diseases and seriousness of the situation. There were numerous negative views on the response and stockpiling of drugs by the government. Ethical awareness of pandemic infectious diseases was high, with demands for accurate information and proper protective equipment. Overall, ethical decision-making when responding to pandemic infectious diseases represented a high score. Also, higher awareness levels of pandemic infectious diseases would result in increased ethical and ethical decision-making. Conclusion: In conclusion, we propose the introduction of an ethical education program for medical personnel and nursing university students, to enable the handling of future pandemic outbreaks of new infectious diseases.

• 디지털융복합연구
• /
• 제18권10호
• /
• pp.335-344
• /
• 2020

본 연구는 코로나-19로 인한 신종감염병 대유행 상황에서 간호대학생의 신종감염병에 대한 인식과 윤리 인식, 윤리적 의사결정 수준을 파악하기 위한 서술적 조사연구이다. 연구대상자는 H읍과 Y시의 간호대학생 3, 4학년 194명이며 2020년 5월 1일부터 6월 20일까지 자료를 수집, SPSS 24.0 프로그램을 이용하여 분석하였다. 연구결과 연구대상자의 신종감염병에 대한 인식은 보통수준이며 윤리 인식과 윤리적 의사결정은 높은 수준이었다. 본인이나 가족의 신종감염병 감염경험이 있는 대상자가 그렇지 않은 대상자보다 윤리 인식과 윤리적 의사결정 수준이 더 높았다. 신종감염병에 대한 인식은 신종감염병 관련 윤리 인식(r=.291, p<.001), 윤리적 의사결정(r=.143, p=.046)과 양의 상관이 있고, 감염병 관련 윤리 인식은 윤리적 의사결정과 양의 상관(r=.274, p<.001)이 있었다. 본 연구 결과를 바탕으로 감염병 대유행 시 간호대학생들의 올바른 윤리적 의사결정을 돕기 위한 교육 프로그램 개발을 제안한다.

• 대한기관윤리심의기구협의회지
• /
• 제4권1호
• /
• pp.5-15
• /
• 2022

To suggest future directions for the improvement in the Institutional Review Board (IRB) review process and efficient operation of IRB, we have analyzed the IRB review results from 460 new research proposals submitted to the Review by the Convened IRB of the Keimyung University Dongsan Hospital IRB from January 2019 to July 2021. IRB is an independently established institutional committee to protect the human subjects by reviewing the research protocol in ethical as well as scientific aspects, so it is necessary to continuously contemplate the ethical versus scientific dilemma of 'what is ethical or scientific and what can actually protect human subjects.' Particularly, in this process, it is necessary to consider diverse ways to strengthen self-supervision through continuous Internal Audit rather than simple reporting outcomes. In addition, if it does not directly affect the protection of the human subjects, the discussion with the committee members is needed so that the comments such as administrative and typographical errors can be reduced as much as possible. Furthermore, as statistical analysis methods can have a significant impact on the safety of human subjects, if a legal basis and/or support related to statistics is provided for the composition of IRB members, a more specialized IRB review will be achieved.

• 대한기관윤리심의기구협의회지
• /
• 제4권1호
• /
• pp.16-22
• /
• 2022

Purpose: The traditional ethical study only suggests a blurred insight on the research using medical big data, especially in this rapid-changing and demanding environment which is called "4th Industry Revolution." Current institutional/ethical issues in big data research need to approach with the thoughtful insight of past ethical study reflecting the understanding of present conditions of this study. This study aims to examine the ethical issues that are emerging in recent health care big data research. So, this study aims to survey the public perceptions on of health care big data as part of the process of public discourse and the acceptance of the utility and provision of big data research as a subject of health care information. In addition, the emerging ethical challenges and how to comply with ethical principles in accordance with principles of the Belmont report will be discussed. Methods: Survey was conducted from June 3th August to 6th September 2020. The online survey was conducted through voluntary participation through Internet users. A total of 319 people who completed the survey (±5.49%P [95% confidence level] were analyzed. Results: In the area of the public's perspective, the survey showed that the medical information is useful for new medical development, but it is also necessary to obtain consents from subjects in order to use that medical information for various research purposes. In addition, many people were more concerned about the possibility of re-identifying personal information in medical big data. Therefore, they mentioned the necessity of transparency and privacy protection in the use of medical information. Conclusion: Big data on medical care is a core resource for the development of medicine directly related to human life, and it is necessary to open up medical data in order to realize the public good. But the ethical principles should not be overlooked. The right to self-determination must be guaranteed by means of clear, diverse consent or withdrawal of subjects, and processed in a lawful, fair and transparent manner in the processing of personal information. In addition, scientific and ethical validity of medical big data research is indispensable. Such ethical healthcare data is the only key that will lead to innovation in the future.

• 한국의상디자인학회지
• /
• 제16권3호
• /
• pp.219-238
• /
• 2014

This study attempted to investigate present condition and product planning of global eco-fashion brands that harmonize fashion and sustainability. As research subjects, this study selected 97 oversea fashion brands mentioned in books related to eco-fashion, Black(2011), Brown(2010), Fuad-luke(2009). As for research methods, materials and ethical practices of these selected 97 brands through literature data and their internet site homepages. This study analyzed oversea eco-brands collected 26 British brands, 22 American brands, 36 European brands such as Germany, France, Italy, Sweden, Spain, Finland and so on, except Britain and 13 other regions including Japan, India, Canada, Mexico, and New zealand. In conclusion, the product planning characteristics of these oversea eco-fashion brands can be summarized as follows; community and fair trade, ecological and slow design, recycle, reuse, redesign, and new eco-models. Firstly, brands of 'community and fair trade' manufactured products through fair trade and local community's artisan by ethical practices with organic fabrics. Secondly, brands of 'ecological and slow design' pursued timeless design and multi-functional design as luxury eco-fashion styles. They used organic textiles, hemp, bamboo, soya, tencell, sea cell, and self-sustaining plants. Thirdly, brands of 'recycle, reuse, redesign' aimed for upcycling high-end fashion and used vintage clothes, textile scraps, PET, parachutes, tires, safety belts, advertising banner and so on. In addition, brands of 'new models as eco-fashion' suggested zero-waste cutting, recycling over-printing technology, new sustainable business model, and ethical practices in the supply chain of the fashion industry.

• 간호행정학회지
• /
• 제9권4호
• /
• pp.541-557
• /
• 2003

Purpose: This descriptive study was designed to explore the clinical nurse's ethical value regarding human life. Method: Data were collected from September to October, 2002. Study subjects were 527 clinical nurses working in General Hospital as tertiary located in Seoul. Ethical value was measured with questionnaire developed by researchers and consisted on items regarding ethical value on human life. Result: Among the items, most nurses highly agree with the item, "When a patient requests his/her health care provider to keep his/her personal secret, the health care provider is obliged to do so." and "When a patient asks for information on his/her medicinal and dietary contents, his/her wish must be granted." Most clinical nurses mainly agree with the item. "Health care providers must always be honest to the patient and/or his/her family". However, most nurses disagree with the item, "When a patient is on the verge of death after an accident, it is justifiable to soothe his/her family by saying 'he/she is OK' instead of telling them the truth, in order to avoid a sudden shock befalling on them". Most clinical nurses mainly disagree with the items, "When a patient is on the verge of death after an accident, it is justiable to soothe his/her family by saying 'he/she is OK' instead of telling them the truth, in order to avoid a sudden shock befalling on them" and "It is justiable that various new ways of treatment should be applied to patient at his/her terminal stage to prolong his/her life, even for the purpose of research". There were significant differences in some items of ethical value according by clinical nurse's age and professional experience, current position, religion, education, marital status, continued education on ethics, and the experience of holing on life saving treatment. Conclusion: It is intensifying the notion of ethical underpinning for human rights, truthfulness is essential to a trust relationship under what circumstances. Also most clinical nurses agree with that It is essential to trust in the nurse-patient relationship, patients have the right to know and it is the ethical thing to do as health care provider.

• 의료법학
• /
• 제13권2호
• /
• pp.79-113
• /
• 2012

This study focuses on the protection of trial subjects, who participate in clinical trials for new drug. It takes long time to develop new drugs and the clinical trials are required. Usually, pharmaceutical company, which develop new drug, request a research institution(usually, hospital) to investigate the examination of security and side effects of new drug. The institution recruit trial subject to participate in the trials. The contract for clinical research of investigational new drug is concluded between the pharmaceutical company and the institution. This thesis studies the legal regulations for protection of participants of clinical research for new drug. In this respect the first matter of this study is to seek which relation between pharmaceutical firm and participants of clinical trials. Especially, there is a question which the trial subject is entitled to demand the pharmaceutical company which requested clinical trials the institution to supply the investigational new drug, after the contract for clinical trials had terminated or cancelled. This study take into account the liability of the pharmaceutical company to trial subject. Secondly, it is researched the roles and authority of Institutional Review Board(IRB). IRB is Research Ethics Committee of the institution, in which clinical trials for new drug are conducted. According to the rule of Korea good clinical practice(KGCP), IRB is the mandatory organization which is authorized to approve, secure approval or disapprove the clinical trials for investigational new drug in the institution. The important roles are the review of ethical perspective of trial research and the protection of trial subject. Thirdly, this paper focuses if the participants are to be paid for the participation for clinical research. This is ethical aspect of clinical trials. It is resonable that the participant is reimbursed for expenditure such as travels, and other expenses incurred in participation in trials. It is not allowed that the benefit of clinical trials is paid to trial subject. The payment should not function as financial inducements for participations of trials. Finally, the voluntary consent of the trial subject is required. The institution ought to inform the subject, who would like to participate in trials, and it ought to received informed consent in writing for subject. In this regard, it is matter that trial subject has ability of consent. It is principle that the subject as severely psychogeriatric patient has not ability of consent. However, it is required that not only healthy people but also patients are allowed to take part in clinical trials of new drug, in order to confirm which the investigation new drug is secure. Therefore there are cases, in which the legal representative of subject consent the participation of the trials. In addition, it is very important that the regulations concerning clinical trials of new drug is to be systematically well-modified. The approach of legal and political approach is needed to achieve this purpose.

• 한국의료윤리학회지
• /
• 제21권4호
• /
• pp.330-343
• /
• 2018

4차 산업혁명시대가 도래했다는 관심이 증가되면서 이에 따른 윤리적 이슈에 대한 탐구 및 대학 교육의 방향에 대한 제고가 필요하게 되었다. 본 논문의 목적은 4차 산업혁명 시대의 대표적 기술분야인 인공지능, 빅데이터, 유전체 기술, 가상현실의 윤리적 이슈 및 국내외 정책과 교육 현황을 살펴보고 앞으로 대학의 생명윤리교육이 나아가야 할 방향을 제안하는 것이다. 4차 산업혁명시대의 국내외 정책과 교육현황을 요약하면, 국외는 4차 산업혁명 기술의 잠재적 이득과 사회적 위험에 대한 법적, 윤리적 고려를 바탕으로 관련 가이드 라인 및 규제 권고안이 발표되었고, 과학 기술의 발전에 따른 학생들의 윤리적 가치 확립의 중요성이 정책적으로 강조됨에 따라 4차 산업혁명시대의 기술개발과 관련된 생명윤리교육과정이 개설된 바 있으며, 대학 내 윤리실험실 개설, 공개 토론회를 넘어 온라인 공개 강좌를 통해 생명윤리 교육의 접근성을 높이고 있다. 국내의 경우에도 최근 공청회 등을 통해 4차 산업시대의 정책방향에 대한 논의가 이루어지고 있으며, 대학교육 또한 시대적 흐름에 맞는 생명윤리 교육을 제공하기 위한 시도가 이루어지고 있다. 그러나 국내 대학의 생명윤리교육은 전통적인 생명윤리 주제에 새로운 과학기술로 야기된 윤리적 이슈를 일부 추가하여 운영되는 교육과정이 대부분이며, 단일 전공 교수자의 강의 운영, 선택 과목, 비정기적인 강의 개설, 그리고 온라인 공개 강좌의 부재 등의 제한점이 확인되었다. 이에 따라, 본 논문에서는 추후 국내 대학의 생명윤리교육을 개선하기 위한 방안을 다음과 같이 제안하고자 한다; 국내 대학의 생명윤리교육은 다직군 간 교육으로 개발되고, 점진적으로 필수 교육과정으로 지정하여 교육의 기회를 확보하며, 온라인 공개 강좌로 확대 개설할 필요가 있다. 또한, 대학 내 생명윤리 이슈에 관한 공개 토론의 장을 마련하고 과학기술의 발전과 그 변화를 함께할 수 있도록 주기적인 논의를 통해 생명윤리교육의 내용을 지속적으로 개선해야 할 것이다.

• 과학기술학연구
• /
• 제18권3호
• /
• pp.1-45
• /
• 2018

한국은 최근 세계 임상시험 중심지의 하나로 떠올랐다. 임상시험을 가장 많이 한 국가 순위에서 미국과 독일 등 전통적 제약 강국에 이어 6위를 차지했고, 도시별 순위에선 서울이 1위 자리에 올랐다. 이 논문은 한국에서 임상시험이 급격하게 증가한 배경으로 수요공급의 시장 메카니즘 외에 다른 요인, 즉 정부의 임상시험 산업화 정책이 중요했음을 보일 것이다. 1990년대 말 금융위기 이후 정부는 바이오테크놀로지(BT)를 차세대 국가 성장 동력으로 정하고 이를 위한 정책개발에 심혈을 기울였다. 바로 이러한 맥락에서 다국적 제약사의 임상시험을 국내에 유치하고 이 분야를 키울 계획을 세우게 된 것이다. 정부가 제도정비, 인프라 구축, 관련 인력 양성 및 국민의식 개선 등의 작업을 수행하는 가운데, 해외 CRO(Contract Research Organization: 임상시험수탁기관)가 들어와 사업을 시작했고, 국내 업체들도 생겨났다. 한국에서 임상시험은 정부에 의해 '초대?된 것이다. 이 논문은 한국의 임상시험 산업화 과정 속에 묻혀있는 생명윤리의 문제를 끄집어내 다루고자 한다. 이를 위해 최근 인류학과 과학기술학에서 논의되고 있는 ??생명자본?? (biocapital)과 ??윤리 가변성??(ethical variability)의 개념을 활용하여, 임상시험을 둘러싼 주요 행위자인 정부 담당자, CRO 직원, 병원 의료진, 환자 등이 실제로 어떤 동기와 목적을 가지고 여기에 참여했는지를 사회 구조적 관점에서 분석할 것이다. 임상시험 참여자의 동의서를 받고, IRB의 심의를 통과하고, 국제기준을 충분히 만족시킨다고 해도, 실제 상황에선 생명윤리의 원칙이 무시될 여지는 충분히 있고, 국가의 산업육성 프레임 안에서 생명윤리는 관련 서류를 갖추면 되는 절차상의 문제로 환원될 수 있음을 보일 것이다.

• 간호행정학회지
• /
• 제1권2호
• /
• pp.268-284
• /
• 1995

This study was designed to test effects of nursing ethics education (NEE) on moral reasoning and ethical decision making of subjects. This NEE that was teached for 10 hours course was composed of these : Nurses' ethical code, moral responsibility, Moral value and professional accountability, Respect for human life, General ethics, Theory and Norms of biomedical ethics, Ethical decision making model and Discussion about hypothetical ethical dilemmas Twenty-five senior student nurses were sampled from four year college of nursing from Nov. 3rd, 1993 to Nov. 24th, 1993. Data were collected through self-reported questionnaires included two kinds of tests. Rest's Defining Issues Test was adopted to measure the stage of moral development, which was classified with the stage 2 (instrumental relativist orientation), the stage 3 (interpersonal concordance), the stage 4 (law and order), the stage 5A (societal consensus), and the stage 5B (intuitional humanism), the stage 6 (universal ethical practice). In particular, the level of principled thinking (P) was measured by summing these scores of the stages 5A, 5B, and 6. The possible range of P is 0 to 95. As for measuring the levels of morality and nursing dilemma, Crisham's Nursing Dilemma Test was adopted. This test generated the morality score(MS) and the dilemma score (DS). The data were analyzed by t-test, ANOVA, Kruskal-Wallis test, Mc Nemar's test and Pearson correlation coefficients. The results were as follows ; 1. For the Moral Reasoning both before and after NEE, The Mean score of the stage 5A was significantly higher than that of other stages.(P=0.0001) Before NEE, the mean score of the stage 4 was significantly different from stage 2, 3, 5A, and after NEE, different from stage 2, 5B,6. 2. The analysis of change of moral development level revealed that the score of stage 4 increased after NEE.(P=0.0004) 3. The Effect of NEE for the mean score of 5A, 6, P after education was significantly different by birth place. 4. With regard to the five dilemmas postulated such as forcing medication performing cardiac pulmonary resuscitation, reporting a medication error, informing diagnosis to terminally ill adult, and providing new-nurse orientation, the mean score of the MS and the DS was no significant difference with general characteristics of the students. Effect of NEE morality score and dilemma score after education was no significant difference. 5. As for the correlations between moral reasoning and decision making, the score of the stage 2, 5A, 6, DS was positively correlated with the scores of before and after. Positive correlation was also observed between the scores of stage 2 and stage 4, stage 3 and 6. On the other hand, the score of P was negatively correlated with the scores of stage 2 and of stage 4 and of stage 5A. The score of the stage 5A was also negatively correlated with the score of the sge 6.